AmpliPhi Biosciences Corp Contracts & Agreements

Second Amendment to Credit and Security Agreement, dated as of November 12, 2024, by and among the Issuer, Innoviva Sub and the other parties thereto (Filed With SEC on November 15, 2024)

Third Amendment to Secured Convertible Credit and Security Agreement, dated as of November 12, 2024, by and among the Issuer, Innoviva Sub and the other parties thereto (Filed With SEC on November 15, 2024)

Confidential Separation and Release Agreement by and between Armata Pharmaceuticals, Inc. and Richard Rychlik dated as of September 30, 2024 (Filed With SEC on October 3, 2024)

Employment Letter Agreement, dated July 31, 2024, by and between Armata Pharmaceuticals, Inc. and David House (Filed With SEC on August 15, 2024)

Amendment No. 1, dated as of July 22, 2024, to that certain Employment Letter Agreement by and between Mina Pastagia, M.D. and Armata Pharmaceuticals, Inc., dated as of September... (Filed With SEC on July 25, 2024)

Employment Letter Agreement by and between Mina Pastagia, M.D. and Armata Pharmaceuticals, Inc., dated as of September 22, 2020 (Filed With SEC on July 25, 2024)

Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 21, 2024)

Employment Agreement, dated August 30, 2023, by and between the Company and Richard Rychlik (Filed With SEC on March 21, 2024)

Credit and Security Agreement, dated March 4, 2024 (Filed With SEC on March 4, 2024)

First Amendment to Credit and Security Agreement (Filed With SEC on March 4, 2024)

Second Amendment to Convertible Credit and Security Agreement (Filed With SEC on March 4, 2024)

Separation and Release Agreement, dated July 14, 2023 (Filed With SEC on July 19, 2023)

Credit and Security Agreement, dated July 10, 2023 (Filed With SEC on July 11, 2023)

First Amendment to Secured Convertible Credit and Security Agreement (Filed With SEC on July 11, 2023)

First Amendment to Second A&R Voting Agreement (Filed With SEC on July 11, 2023)

Letter Agreement, dated July 10, 2023, by and between the Company and Deborah Birx (Filed With SEC on July 11, 2023)

Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 16, 2023)

Secured Convertible Credit and Security Agreement, dated January 10, 2023 (Filed With SEC on January 10, 2023)

Letter Agreement, dated December 14, 2022, by and between Armata Pharmaceuticals, Inc. and Todd R. Patrick (Filed With SEC on December 19, 2022)

Advisory Agreement, dated March 28, 2022, between the Company and Mr. Martin (Filed With SEC on March 28, 2022)

Employment Agreement, dated March 28, 2022, between the Company and Ms. Butler (Filed With SEC on March 28, 2022)

Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 17, 2022)

Form of Common Stock Warrant (Filed With SEC on February 11, 2022)

Securities Purchase Agreement, dated February 9, 2022, by and between the Company and Innoviva (Filed With SEC on February 11, 2022)

Second Amended and Restated Investors Rights Agreement, dated February 9, 2022, by and among the Company, Innoviva, Inc. and Innoviva (Filed With SEC on February 11, 2022)

Registration Rights Agreement, dated February 9, 2022, by and between the Company and Innoviva (Filed With SEC on February 11, 2022)

Amended and Restated Voting Agreement, dated February 9, 2022 by and between the Company, Innoviva, Inc. and Innoviva (Filed With SEC on February 11, 2022)

Lease Agreement, dated October 28, 2021, by and between Armata Pharmaceuticals, Inc. and 5005 McConnell Avenue, LLC (Filed With SEC on November 2, 2021)

Securities Purchase Agreement, dated October 28, 2021, by and among the Company, Innoviva and CFF (Filed With SEC on October 29, 2021)

Registration Rights Agreement, dated October 28, 2021, by and among the Company, Innoviva and CFF (Filed With SEC on October 29, 2021)

Amended and Restated Voting Agreement, dated October 28, 2021, by and among the Company, Innoviva and Innoviva, Inc (Filed With SEC on October 29, 2021)

Employment Agreement, dated August 1, 2021, between Armata Pharmaceuticals, Inc. and Brian Varnum, Ph.D (Filed With SEC on August 12, 2021)

Amended Employment Agreement, dated August 9, 2021 between Armata Pharmaceuticals, Inc. and Todd Patrick (Filed With SEC on August 12, 2021)

Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 18, 2021)

Form of Common Stock Warrant (Filed With SEC on January 27, 2021)

Securities Purchase Agreement, dated January 26, 2021, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)

Form of Amended and Restated Investors Rights Agreement, by and among the Company and Innoviva (Filed With SEC on January 27, 2021)

Form of Registration Rights Agreement, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)

Form of Voting Agreement, by and between the Company and Innoviva (Filed With SEC on January 27, 2021)

Letter Agreement, dated as of March 10, 2020, by and between Armata Pharmaceuticals, Inc. and the Cystic Fibrosis Foundation (Filed With SEC on May 14, 2020)

Employment Agreement, dated as of January 18, 2012, by and between C3 Jian, Inc. and Brian Varnum (Filed With SEC on May 14, 2020)

Assignment and First Amendment of Office Lease, dated as of April 2020, by and among Armata Pharmaceuticals, Inc., C3 Jian, Inc. and Marina Business Center, LLC (Filed With SEC on May 14, 2020)

Description of the Companys securities registered under Section 12 of the Exchange Act (Filed With SEC on March 19, 2020)

Registration Rights Agreement, dated February 12, 2020, by and between the Company and Innoviva (Filed With SEC on February 13, 2020)

Investor Rights Agreement, dated February 12, 2020, by and between the Company and Innoviva (Filed With SEC on February 13, 2020)

Form of Common Stock Warrant (Filed With SEC on January 29, 2020)

Securities Purchase Agreement, dated January 27, 2020, by and between the Company and Innoviva (Filed With SEC on January 29, 2020)

Form of Investor Rights Agreement, by and the Company and Innoviva (Filed With SEC on January 29, 2020)

Form of Voting Agreement, to be entered into by and between Innoviva and certain stockholders of the Company (Filed With SEC on January 29, 2020)

Form of Stock Option Grant Notice, Option Agreement and Notice of Exercise under the Armata Pharmaceuticals, Inc. 2016 Equity Incentive Plan (Filed With SEC on August 14, 2019)

Armata Pharmaceuticals, Inc. 2016 Employee Stock Purchase Plan (Filed With SEC on August 14, 2019)

Asset Purchase Agreement, dated as of February 14, 2018, by and between C3J Therapeutics, Inc., Synthetic Genomics, Inc. and Synthetic Genomics Vaccines, Inc., as amended by... (Filed With SEC on August 14, 2019)

Research Collaboration and Option to License Agreement, effective as of May 24, 2017, by and between Synthetic Genomics, Inc. and Merck Sharp & Dohme Corp (Filed With SEC on August 14, 2019)

Form of the Armata Pharmaceuticals, Inc. Common Stock Certificate (Filed With SEC on May 10, 2019)

Registration Rights Agreement, dated as of May 9, 2019, by and among Armata Pharmaceuticals, Inc. and the Investors (Filed With SEC on May 10, 2019)

Employment Agreement, dated October 1, 2018, between C3J Therapeutics, Inc. and Todd R. Patrick (Filed With SEC on May 10, 2019)

Amendment to Employment Agreement, dated as of January 16, 2019, between C3J Therapeutics, Inc. and Todd R. Patrick (Filed With SEC on May 10, 2019)

Form of Director Appointment Letter (Filed With SEC on May 10, 2019)

Amendment, dated March 25, 2019, to Agreement and Plan of Merger and Reorganization, dated January 3, 2019, by and among the Company, C3J Therapeutics and Merger Sub (Filed With SEC on March 25, 2019)

Engagement letter agreement, dated December 13, 2017, as amended on December 17, 2018, by and between the Company and Ladenburg Thalmann & Co. Inc (Filed With SEC on March 25, 2019)

Form of Share Purchase Agreement by and among AmpliPhi Biosciences Corporation, C3J Therapeutics, Inc. and certain shareholders of C3J Therapeutics, Inc., dated as of February 5,... (Filed With SEC on February 7, 2019)

Form of Company Support Agreement, dated January 3, 2019, by and between C3J Therapeutics and each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)

Form of C3J Therapeutics Support Agreement, dated January 3, 2019, by and between the Company and each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)

Form of Company Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)

Form of C3J Lock-Up Agreement, dated January 3, 2019, by each of the parties named in each agreement therein (Filed With SEC on January 4, 2019)

Agreement and Plan of Merger and Reorganization, dated January 3, 2019, by and among the Company, C3J Therapeutics and Merger Sub (Filed With SEC on January 4, 2019)

Form of Underwriting Agreement (Filed With SEC on October 9, 2018)

Form of Pre-Funded Warrant (Filed With SEC on October 9, 2018)

Form of Warrant to Purchase Common Stock (Filed With SEC on October 9, 2018)

Form of Underwriting Agreement (Filed With SEC on September 18, 2018)

Form of Pre-Funded Warrant (Filed With SEC on September 18, 2018)

ExhibitA SEPARATION AGREEMENT AND RELEASE (Filed With SEC on August 14, 2017)

[ ] Shares of Common Stock Pre-Funded Warrants to Purchase [ ]Shares of Common Stock and Warrants to Purchase [ ] Shares of CommonStock AMPLIPHI BIOSCIENCES CORPORATION... (Filed With SEC on May 1, 2017)

COMMON STOCK PURCHASE WARRANT AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on May 1, 2017)

PRE-FUNDED WARRANT TO PURCHASE COMMON STOCK AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on May 1, 2017)

COMMON STOCK PURCHASE WARRANT AMPLIPHIBIOSCIENCES CORPORATION (Filed With SEC on November 17, 2016)

COMMON STOCK PURCHASE WARRANT AMPLIPHIBIOSCIENCES CORPORATION (Filed With SEC on November 16, 2016)

COMMON STOCK PURCHASE WARRANT AMPLIPHIBIOSCIENCES CORPORATION (Filed With SEC on November 10, 2016)

[_________] Shares of Common Stock and Warrants to Purchase [_____] Shares ofCommon Stock AMPLIPHI BIOSCIENCES CORPORATION UNDERWRITING AGREEMENT (Filed With SEC on September 14, 2016)

AMPLIPHI BIOSCIENCES CORPORATION WARRANT TO PURCHASE COMMON STOCK (Filed With SEC on September 14, 2016)

COMMON STOCK PURCHASE WARRANT AMPLIPHIBIOSCIENCES CORPORATION (Filed With SEC on June 1, 2016)

AMPLIPHIBIOSCIENCES CORPORATION COMMONSTOCK ISSUANCE AGREEMENT (Filed With SEC on April 8, 2016)

WARRANTTO PURCHASE COMMON STOCK OF AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on March 30, 2016)

AMPLIPHI BIOSCIENCES CORPORATION Common Stock Purchase Warrant (Filed With SEC on March 30, 2016)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on March 30, 2016)

AMPLIPHIBIOSCIENCES CORPORATION 2013 STOCK INCENTIVE PLAN NOTICEOF STOCK OPTION AWARD (Filed With SEC on March 30, 2016)

US: 4870 Sadler Rd. Suite 300, Glen Allen, VA23060 AU: Unit 7 27 Dale Street, Brookvale 2100 NSW (Filed With SEC on March 30, 2016)

DATED 4th November 2015 (“AgreementDate”) (Filed With SEC on March 30, 2016)

ASSET PURCHASEAGREEMENT (Filed With SEC on March 30, 2016)

AMPLIPHI BIOSCIENCES CORPORATION CONSULTING AGREEMENT (Filed With SEC on November 16, 2015)

AMENDMENT TO WARRANTS TO PURCHASE SHARES OF COMMON STOCK OF AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on May 15, 2015)

AMENDMENT TO INTERIM CHIEF OPERATINGOFFICER AGREEMENT (Filed With SEC on April 16, 2015)

SUBSCRIPTION AGREEMENT (Filed With SEC on March 19, 2015)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF AMPLIPHI BIOSCIENCES CORPORATION (Filed With SEC on March 19, 2015)

REGISTRATIONRIGHTS AGREEMENT (Filed With SEC on March 19, 2015)

AMPLIPHIBIOSCIENCES CORPORATION INTERIMCHIEF OPERATING OFFICER AGREEMENT (Filed With SEC on November 14, 2014)

Schedule 1 Relevant PatentApplications (Filed With SEC on January 21, 2014)

TABLE OF CONTENTS (Filed With SEC on January 21, 2014)

AGREEMENT AND PLAN OF MERGER (Filed With SEC on January 21, 2014)

EIGHTH AMENDMENT TO LEASE AGREEMENT AND CONDITIONAL TERMINATION OF LEASE (Filed With SEC on November 16, 2009)

NINTH AMENDMENT TO AND CONTINUATION OF LEASE AGREEMENT (Filed With SEC on November 16, 2009)

NINTH AMENDMENT TO LEASE AGREEMENT AND CONDITIONAL TERMINATION OF LEASE (Filed With SEC on November 16, 2009)

ASSET PURCHASE AGREEMENT (Filed With SEC on November 16, 2009)

AMENDMENT NO. 4 TO EXCLUSIVE SUBLICENSE AGREEMENT (Filed With SEC on August 12, 2009)

EIGHTH LEASE AMENDMENT between (Filed With SEC on August 12, 2009)

SEVENTH AMENDMENT TO LEASE AGREEMENT (Filed With SEC on August 12, 2009)

LEASE TERMINATION AGREEMENT (CANYON PARK EAST) (Filed With SEC on August 12, 2009)

TARGETED GENETICS CORPORATION STOCK INCENTIVE PLAN (Filed With SEC on August 12, 2009)

LICENSE AGREEMENT Supersedes and replaces Collaboration Agreement (Filed With SEC on May 7, 2009)

AMENDED AND RESTATED MANUFACTURING AGREEMENT (Filed With SEC on May 7, 2009)

CONFIDENTIAL UNIVERSITY OF PENNSYLVANIA AMENDED AND RESTATED LICENSE AGREEMENT (Filed With SEC on May 7, 2009)

SENIOR MANAGEMENT EMPLOYMENT AGREEMENT (Filed With SEC on March 31, 2009)

FIFTH LEASE AMENDMENT between BENAROYA CAPITAL COMPANY, LLC and (Filed With SEC on March 31, 2009)

TARGETED GENETICS CORPORATION SEPARATION AGREEMENT AND RELEASE (Filed With SEC on November 26, 2008)

AMENDED AND RESTATED SENIOR MANAGEMENT EMPLOYMENT AGREEMENT (Filed With SEC on March 12, 2008)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on June 25, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on June 25, 2007)

COMMON STOCK PURCHASE WARRANT TARGETED GENETICS CORPORATION (Filed With SEC on June 25, 2007)

*Certain confidential information contained in this document, marked by brackets, has been omitted and filed with the Securities and Exchange Commission pursuant to Rule 24b-2 of... (Filed With SEC on March 29, 2007)

SECURITIES PURCHASE AGREEMENT (Filed With SEC on January 8, 2007)

REGISTRATION RIGHTS AGREEMENT (Filed With SEC on January 8, 2007)

WARRANT TO PURCHASE SHARES OF COMMON STOCK OF TARGETED GENETICS CORPORATION (Filed With SEC on January 8, 2007)

AMENDMENT NO. 3 TO FUNDING AGREEMENT (Filed With SEC on November 7, 2006)

AMENDED AND RESTATED PROMISSORY NOTE $2,000,000 November 7, 2006 (Filed With SEC on November 7, 2006)

The Childrens Hospital of Philadelphia Joseph Stokes, Jr., Research Institute Department of Sponsored Projects 3615 Civic Center Blvd. ARC 142 Philadelphia, PA 19104-4318 Phone... (Filed With SEC on November 1, 2006)

CHANGE IN CONTROL AGREEMENT (Filed With SEC on September 20, 2006)

SEVENTH LEASE AMENDMENT between MET PARK WEST IV, LLC and TARGETED GENETICS CORPORATION (Filed With SEC on June 21, 2006)

Diverse product development pipeline. Each of our clinical and preclinical product candidates addresses a different market: in each case where we believe there is significant... (Filed With SEC on March 16, 2006)

Description of Document (Filed With SEC on March 10, 2006)

Current assets (Filed With SEC on July 30, 2004)

Legal Proceedings (Filed With SEC on March 12, 2004)

FINANCIAL INFORMATION (Filed With SEC on October 31, 2003)

FIFTH AMENDMENT TO LEASE AGREEMENT (Filed With SEC on July 22, 2003)

Amendment to Funding Agreement (Filed With SEC on July 22, 2003)

PLACEMENT AGENCY AGREEMENT (Filed With SEC on June 13, 2003)

BIOLOGICAL PROCESSING SERVICES AGREEMENT (Filed With SEC on May 15, 2003)

Study Funding Agreement (Filed With SEC on May 15, 2003)

TARGETED GENETICS CORPORATION THIRD AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on March 27, 2003)

Settlement and Termination Agreement (Filed With SEC on March 27, 2003)

EXHIBIT10.41 TO (Filed With SEC on March 27, 2003)

EXHIBIT10.42 TO (Filed With SEC on March 27, 2003)

INDUSTRIAL COLLABORATION AGREEMENT (Filed With SEC on November 14, 2002)

TARGETED GENETICS CORPORATION SECOND AMENDMENT TO RIGHTS AGREEMENT (Filed With SEC on October 11, 2002)

Category

Industry

Companies

Contracts

AmpliPhi Biosciences Corp Contracts & Agreements